Descriptive epidemiology of ovarian cancer in the United States, 1992–1997

Descriptive Epidemiology of Ovarian Cancer in the United States, 1992-1997 Marc T. Goodman and Holly L. Howe Ovarian cancer is relatively uncommon, and therefore little has been published to date regarding racial or ethnic variations in the incidence or mortality of this malignancy. As the U.S. population becomes more diverse, the interest in health problems and disparities in outcomes among minority and economically disadvantaged groups will continue to increase. In this supplement, the authors focus on epidemiology, pathology and classification issues, multiple primary tumors, staging, and incidence and mortality for race/ethnic groups. The authors also focused on epidemiologic differences between borderline tumors of low malignant potential and carcinomas.

[1]  H. Howe,et al.  Pathology and classification of ovarian tumors , 2003, Cancer.

[2]  L. Wilkens,et al.  Stage at diagnosis of ovarian cancer in the United States, 1992–1997 , 2003, Cancer.

[3]  B. Kohler,et al.  Multiple primary cancers of the ovary in the United States, 1992–1997 , 2003, Cancer.

[4]  H. Howe,et al.  Incidence of extraovarian primary cancers in the United States, 1992–1997 , 2003, Cancer.

[5]  S. Coughlin,et al.  Race/ethnic variations in ovarian cancer mortality in the United States, 1992–1997 , 2003, Cancer.

[6]  H. Howe,et al.  Ovarian cancer in children and young adults in the United States, 1992–1997 , 2003, Cancer.

[7]  H. Howe,et al.  Regional variations in ovarian cancer incidence in the United States, 1992–1997 , 2003, Cancer.

[8]  S. Coughlin,et al.  Incidence of ovarian cancer by race and ethnicity in the United States, 1992–1997 , 2003, Cancer.

[9]  Alexander Tsodikov,et al.  A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? , 2002, Gynecologic oncology.

[10]  A. Whittemore,et al.  Race, Epithelial Ovarian Cancer Survival, and Membership in a Large Health Maintenance Organization , 2002, Epidemiology.

[11]  J. Cerhan,et al.  Association of Parity and Ovarian Cancer Risk by Family History of Breast or Ovarian Cancer in a Population-Based Study of Postmenopausal Women , 2002, Epidemiology.

[12]  P. Dickman,et al.  Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. , 2001, Gynecologic oncology.

[13]  R. Ness,et al.  Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. , 2001, Annals of epidemiology.

[14]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[15]  M. Noguchi,et al.  Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. , 2000, Cancer research.

[16]  J. Gohagan,et al.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.

[17]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[18]  R. Scully Influence of origin of ovarian cancer on efficacy of screening , 2000, The Lancet.

[19]  R. Tarone,et al.  Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA. , 2000, Journal of epidemiology and biostatistics.

[20]  D. Parkin,et al.  The performance of screening tests for ovarian cancer: results of a systematic review , 1999, British journal of obstetrics and gynaecology.

[21]  R. Ness,et al.  Possible role of ovarian epithelial inflammation in ovarian cancer. , 1999, Journal of the National Cancer Institute.

[22]  P. Sorlie,et al.  Quality of death rates by race and Hispanic origin: a summary of current research, 1999. , 1999, Vital and health statistics. Series 2, Data evaluation and methods research.

[23]  Steven J Skates,et al.  Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.

[24]  T. Sellers,et al.  Prospective study of diet and ovarian cancer. , 1999, American journal of epidemiology.

[25]  H. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.

[26]  G. Chenevix-Trench,et al.  Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. , 1998, Journal of the National Cancer Institute.

[27]  K. Kerlikowske,et al.  HORMONE REPLACEMENT THERAPY AND THE RISK OF EPITHELIAL OVARIAN CARCINOMA: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[28]  F. Miller,et al.  Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. , 1998, Radiology.

[29]  G. Parham,et al.  The national cancer data base report on malignant epithelial ovarian carcinoma in African‐American women , 1997, Cancer.

[30]  A. Berchuck,et al.  Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. , 1997, Journal of the National Cancer Institute.

[31]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[32]  E. Feuer,et al.  Confidence intervals for directly standardized rates: a method based on the gamma distribution. , 1997, Statistics in medicine.

[33]  H. Risch,et al.  Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.

[34]  M. Janicek,et al.  The national cancer data base report on ovarian cancer , 1995, Cancer.

[35]  D. Machin Trends in Cancer Incidence and Mortality , 1995, British Journal of Cancer.

[36]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[37]  P. Humphrey,et al.  Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. , 1994, Gynecologic oncology.

[38]  J. Morris,et al.  Epidemiology and prevention. , 1982, The Milbank Memorial Fund quarterly. Health and society.

[39]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[40]  J. Mclaughlin,et al.  Comparability of the death certificate and the 1986 National Mortality Followback Survey. , 1993, Vital and health statistics. Series 2, Data evaluation and methods research.

[41]  H. Hogan The 1990 Post-Enumeration Survey: operations and results. , 1993, Journal of the American Statistical Association.

[42]  C. Johannes,et al.  Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.

[43]  A S Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[44]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[45]  D. Cramer,et al.  Perineal Exposure to Talc and Ovarian Cancer Risk , 1992, Obstetrics and gynecology.

[46]  M. Goodman,et al.  Racial variation in cancer incidence: fact or artifact? , 1992, Journal of the National Cancer Institute.

[47]  S. Lowry,et al.  Incessant ovulation and ovarian cancer , 1991, The Lancet.

[48]  P. Wingo,et al.  The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? , 1991, American journal of obstetrics and gynecology.

[49]  R. Bast,et al.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.

[50]  J. Shepherd Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.

[51]  W. Willett,et al.  GALACTOSE CONSUMPTION AND METABOLISM IN RELATION TO THE RISK OF OVARIAN CANCER , 1989, The Lancet.

[52]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.

[53]  A. Whittemore,et al.  Errors in reported dietary intakes. II. Long-term recall. , 1988, American journal of epidemiology.

[54]  H. Kato,et al.  Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80. , 1987, Journal of the National Cancer Institute.

[55]  N. Weiss,et al.  Epidemiology of borderline ovarian tumors. , 1987, Journal of the National Cancer Institute.

[56]  D. Cramer,et al.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.

[57]  H. Stalsberg An International survey of distributions of histologic types of tumours of the testis and ovary , 1983 .

[58]  C. la Vecchia,et al.  Risk factors for epithelial ovarian cancer in Italy. , 1982, American journal of epidemiology.

[59]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[60]  J. Kelsey,et al.  An epidemiologic study of epithelial carcinoma of the ovary. , 1981, American journal of epidemiology.

[61]  J. Zajicek Prevention of ovarian cystomas by inhibition of ovulation: a new concept. , 1978, The Journal of reproductive medicine.

[62]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.

[63]  B. Stadel The etiology and prevention of ovarian cancer , 1975 .

[64]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.

[65]  Daan Brandenbarg The National. , 1892 .

[66]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.